Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTO.L Regulatory News (CTO)

  • There is currently no data for CTO

Trading Statement

27 Jan 2022 07:00

RNS Number : 7470Z
TClarke PLC
27 January 2022
 

TClarke plc

 

YEAR END TRADING UPDATE

 

NOTICE OF RESULTS

 

TClarke reaffirms strong second half 2021 trading as order book reaches record high

 

TClarke plc ("TClarke" or the "Group"), the Building Services Group, today announces a year end trading update for the full year ended 31 December 2021 ("FY2021").

 

Financial Results

 

The Board is pleased to report that trading in the second half of the year has been excellent and that the Group's financial performance for the full year is in line with its expectations.

 

The Group anticipates reporting turnover for FY2021 of c.£327m and underlying earnings before interest and tax (EBIT) of c.£8.8m. This represents an increase of 47% over the prior year. There are no non-underlying items in FY2021. FY2021 profit before tax is expected to be c.£7.8m (FY2020: £1.2m).

 

New Order Book Record

 

TClarke occupies a premier position in the marketplace, particularly in London.

 

The Group has invested heavily in resources and capacity ensuring that the Group's growth ambitions are fully supported, and our clients' projects continue to be delivered on time.

 

Our order book has now increased to a record level of £534m (2020: £456m) with projects relating to the technology sector accounting for approximately 25% (2020 10%). Importantly the Group has already secured projects worth £379m for 2022 with many more opportunities across all market sectors.

 

Cash Performance

 

Net cash at the year-end was £5.3m (2020: £10.2m) in line with our expectations. The reduction is mainly due to the Group internally funding the working capital required to support the expansion of the business and change of VAT regime. In addition to its net cash the Group has £25m of bank facilities available to it.

Outlook

 

Looking to the future, TClarke is focused on delivering our growth strategy. The Group is expecting turnover to exceed £400m in 2022 before achieving £500m by the end of 2023. The size of the existing order book and the number of opportunities ahead of the Group supports our expectation that we will achieve our targets.

 

Our growth strategy is focused on maintaining and developing our core markets whilst significantly expanding our data centre business. We are also undertaking more large projects outside of London such as those being delivered for a major financial institution by our Manchester business, expanding our healthcare offering (for example we have won a place on the NHS Smart Building framework) and expanding our energy efficient smart building solutions.

 

Commenting, Mark Lawrence, TClarke CEO said:

 

''TClarke has had a tremendous second half of the year delivering a record level of turnover for that period and ending the year with an order book exceeding £530m; another record.

 

During the year, the Group has broadened its offering whilst strengthening our resources so that clients can be assured in our ability to deliver their projects. We are on track to achieve our growth ambitions and I am extremely excited and confident for the outlook for TClarke.''

The Group will be announcing its FY2021 preliminary results on 9 March 2022.

 

-ends-

 

Date: 27 January 2022

 

For further information contact:

 

 

TClarke plc

Mark Lawrence

Group Chief Executive Trevor Mitchell Finance Director

Tel: 020 7997 7400

 www.tclarke.co.uk

 

Cenkos Securities plc (Corporate Broker)

Ben Jeynes (Corporate Finance)

Alex Pollen (Sales)

Tel: 020 7397 8900

 www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPURAGUPPGCQ
Date   Source Headline
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference
11th May 202210:27 amRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
10th May 202212:51 pmRNSESOT Share Purchase
5th May 20223:52 pmRNSESOT Share Purchase
3rd May 20229:03 amRNSDirector/PDMR Shareholding
26th Apr 20224:29 pmRNSVesting of EIP share awards April 2022
20th Apr 20229:27 amRNSChange of Registered Office
8th Apr 202210:09 amRNSPublication of Annual Report and Notice of AGM
8th Apr 20227:00 amRNSDirectorate Change
16th Mar 20228:27 amRNSDirector/PDMR Shareholding
16th Mar 20228:21 amRNSTotal Voting Rights
11th Mar 20227:00 amRNSInvestor Presentation
9th Mar 20227:02 amRNSDirectorate Change
9th Mar 20227:00 amRNSNotification of Investor Presentation
9th Mar 20227:00 amRNSFinal Results
2nd Feb 20223:21 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSNotification of Investor Presentation
27th Jan 20227:00 amRNSTrading Statement
4th Jan 202211:28 amRNSBlock listing Interim Review
9th Dec 20211:11 pmRNSESOT Share Purchase
6th Dec 20219:40 amRNSESOT Share Purchase
3rd Dec 202111:51 amRNSTR-1: Notification of Change of Holding
1st Dec 20213:02 pmRNSPDMR Disclosure
1st Dec 20213:00 pmRNSTotal Voting Rights and Share Capital
25th Nov 20217:00 amRNSTrading Statement
18th Oct 20217:00 amRNSInvestor Presentation
6th Oct 202111:14 amRNSPDMR Holding
6th Oct 202111:10 amRNSBlock Listing Application
22nd Sep 20217:00 amRNSNotice of Investor Presentation
17th Aug 20211:41 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSTClarke Selected for NHS Smart Buildings Framework
20th Jul 20217:00 amRNSHalf-year Report
5th Jul 20217:00 amRNSBlock listing Interim Review
1st Jul 20217:00 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
6th May 20219:04 amRNSTR-1: Notification of major holding in Company
5th May 202111:20 amRNSResult of AGM
5th May 20217:01 amRNSDirectorate Change
5th May 20217:00 amRNSAGM - Trading Update
29th Apr 20217:00 amRNSDirector / PDMR Shareholding
28th Apr 20217:00 amRNSDirector / PDMR Shareholding
12th Apr 202110:40 amRNSESOT Share Purchase
9th Apr 20212:53 pmRNSPublication of Annual Report & Notice of 2021 AGM
6th Apr 202110:39 amRNSESOT Share Purchase
26th Mar 20212:28 pmRNSESOT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.